A new drug delivery system targeting the spleen could provide more effective treatment options for lupus, a debilitating autoimmune disease. The system uses lipid nanoparticles modified with mannose to deliver medicine directly to the spleen and target critical immune cells thought to drive the disease.
A new gene therapy has successfully restored immune function in nine children with severe leukocyte adhesion deficiency-I (LAD-I), a rare genetic disorder. The treatment has eliminated symptoms and reduced severe infections, offering a life-changing benefit to these patients.
Researchers found that acute transient hepatocellular injury occurs in patients with cholelithiasis and cholecystitis without evidence of CBD stones, resolving within weeks after surgery. Markers of liver damage are more severe in those with CBD stones or histologically less severe inflammation.